Drug Development Executive

Drug Development Executive

Share this post

Drug Development Executive
Drug Development Executive
Cardioimmunology: rapidly growing field

Cardioimmunology: rapidly growing field

Atheroscleotic plaque as a tertiary lymphoid organ

Eswar Krishnan, MD's avatar
Eswar Krishnan, MD
May 20, 2025
∙ Paid

Share this post

Drug Development Executive
Drug Development Executive
Cardioimmunology: rapidly growing field
Share

Cardiovascular diseases challenge global health. Traditional risk factors are key, but cardioimmunology shows the immune system's complex role in these diseases, especially in atherosclerosis, now seen as a chronic inflammatory condition. Findings like structured immune cells, termed tertiary lymphoid organs (TLOs), in atherosclerotic plaques, indicate …

Keep reading with a 7-day free trial

Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Eswar Krishnan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share